Candriam SCA’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.1M | Buy |
49,965
+28,593
| +134% | +$8.65M | 0.09% | 199 |
|
|
2025
Q1 | $7.08M | Buy |
+21,372
| New | +$7.08M | 0.04% | 275 |
|
|
2024
Q2 | – | Sell |
-18,000
| Closed | -$4.81M | – | 711 |
|
|
2024
Q1 | $4.81M | Sell |
18,000
-9,000
| -33% | -$2.4M | 0.03% | 350 |
|
|
2023
Q4 | $6.25M | Sell |
27,000
-2,000
| -7% | -$463K | 0.04% | 309 |
|
|
2023
Q3 | $4.24M | Hold |
29,000
| – | – | 0.03% | 326 |
|
|
2023
Q2 | $6.7M | Buy |
+29,000
| New | +$6.7M | 0.05% | 296 |
|
|
2021
Q2 | – | Sell |
-31,722
| Closed | -$3.39M | – | 923 |
|
|
2021
Q1 | $3.39M | Hold |
31,722
| – | – | 0.03% | 437 |
|
|
2020
Q4 | $3.53M | Sell |
31,722
-62,862
| -66% | -$6.99M | 0.03% | 448 |
|
|
2020
Q3 | $11.2M | Sell |
94,584
-8,000
| -8% | -$950K | 0.11% | 209 |
|
|
2020
Q2 | $11.6M | Buy |
102,584
+61,634
| +151% | +$6.98M | 0.12% | 194 |
|
|
2020
Q1 | $3.65M | Hold |
40,950
| – | – | 0.04% | 423 |
|
|
2019
Q4 | $3.73M | Sell |
40,950
-500
| -1% | -$45.6K | 0.04% | 437 |
|
|
2019
Q3 | $3.57M | Hold |
41,450
| – | – | 0.05% | 386 |
|
|
2019
Q2 | $4.33M | Hold |
41,450
| – | – | 0.05% | 362 |
|
|
2019
Q1 | $5.19M | Buy |
41,450
+10,000
| +32% | +$1.25M | 0.07% | 315 |
|
|
2018
Q4 | $3.55M | Buy |
31,450
+17,500
| +125% | +$1.97M | 0.05% | 347 |
|
|
2018
Q3 | $2.99M | Buy |
13,950
+4,550
| +48% | +$974K | 0.04% | 416 |
|
|
2018
Q2 | $2.63M | Buy |
+9,400
| New | +$2.63M | 0.04% | 426 |
|